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Abstract
Production of carbon nanofibers and nanotubes (CNFs/CNTs) and their composite products is 
increasing globally. High-volume production may increase the exposure risks for workers who 
handle these materials. Though health effects data for CNFs/CNTs are limited, some studies raise 
serious health concerns. Given the uncertainty about their potential hazards, there is an immediate 
need for toxicity data and field studies to assess exposure to CNFs/CNTs. An extensive study was 
conducted at a facility that manufactures and processes CNFs. Filter, sorbent, cascade impactor, 
bulk, and microscopy samples, combined with direct-reading instruments, provided 
complementary information on air contaminants. Samples were analyzed for organic and 
elemental carbon (OC and EC), metals, and polycyclic aromatic hydrocarbons (PAHs), with EC as 
a measure of CNFs. Transmission electron microscopy with energy-dispersive X-ray spectroscopy 
also was applied. Fine/ultrafine iron-rich soot, PAHs, and carbon monoxide were production 
byproducts. Direct-reading instrument results were reported previously [Evans DE et al. (Aerosol 
monitoring during carbon nanofiber production: mobile direct-reading sampling. Ann Occup Hyg 
2010; 54:514–31)]. Results for time-integrated samples are reported as companion papers in this 
issue. OC and EC, metals, and microscopy results are reported in Part I [Birch ME et al. (Exposure 
and emissions monitoring during carbon nanofiber production—Part I: elemental carbon and iron–
soot aerosols. Ann Occup Hyg 2011; 55: 1016–36.)] whereas results for PAHs are reported here. 
Naphthalene and acenaphthylene were the dominant PAHs with average concentrations ranging 
from 115 to 336 μg m−3 and 35 to 84 μg m−3, respectively. Concentrations of other PAHs ranged 
from ~1 to 10 μg m−3.
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According to some projections, unprecedented growth in nanotechnologies will broadly 
impact many industrial sectors and require up to 2 million workers globally by year 2015 
(Roco and Bainbridge, 2005). As discussed in a companion paper (Birch et al., 2011), 
market value projections for nanotechnologies differ widely, e.g. from $26 billion to $4 
trillion in 2015, depending on different assumptions and market definitions. The $26 billion 
estimate (BCC Research, 2010) may be more realistic. It includes only nanotechnology 
products (‘nanomaterials’, ‘nanotools’, and ‘nanodevices’) rather than all ‘nanotechnology-
enabled’ products. The largest product segments in 2009 were nanomaterials, having an 
estimated value of $9 billion and a projected increase to ~$19.6 billion in 2015 (BCC 
Research, 2010).
Carbon nanofibers and nanotubes (CNFs/CNTs) are an important class of nanomaterials due 
to their immense potential for industrial and scientific applications. Production of CNFs/
CNTs and composite products is increasing globally, and manufacturing processes are 
rapidly changing. In 2004, an annual global production of CNFs and CNTs was reported as 
65 tons per year (Cientifica 2005). Applications of CNTs include electronics, flat panel 
displays, batteries and fuel cells, thermoplastic additives (to impart conductivity), and 
biomedical science. At relatively low loadings, CNFs are being used to improve the thermal, 
electrical, and mechanical properties of a wide variety of polymer-based composite 
materials. Applications include high-performance products, such as coatings and composites 
for aerospace, automobiles, sports equipment, and construction.
High-volume production of CNFs/CNTs may pose an exposure risk for workers, especially 
manual handling in open areas. Inflammation, pulmonary fibrosis, granulomas, oxidative 
stress, and mutagenicity have been observed in inhalation studies of mice exposed to single-
walled CNTs (SWCNTs) (Shvedova et al., 2005, 2008). Dermal inflammation also has been 
reported (Murray et al., 2009). More alarming is the prospect of asbestos-like pathology, as 
reported for multi-walled CNTs (MWCNTs) injected into the abdominal cavities of mice 
(Poland et al., 2008). A similar study of CNFs has not been conducted, but acute 
inflammation and pulmonary fibrosis were observed in mice exposed by pharyngeal 
aspiration (Kisin et al., 2010), and CNFs are similar to MWCNTs in some respects. Their 
diameters are comparable, with CNFs typically in the 50–200 nm range (Ku et al., 2006) 
and MWCNTs having diameters up to 100 nm (Wang et al., 2006); they have tubular 
structures; and the tubes/fibers typically form bundled/entangled structures. In contrast, 
SWCNTs have much smaller diameters (e.g. 1–3 nm) and form highly entangled structures 
(Shvedova et al., 2005; Maynard et al., 2007). The differences between and definitions of 
CNFs and CNTs are discussed in a companion paper (Birch et al., 2011).
A review of the current toxicological literature and draft risk assessment on CNFs and CNTs 
was recently released by the National Institute for Occupational Safety and Health (NIOSH, 
2010) for public comment. A single recommended exposure limit (REL) was proposed (7 μg 
m−3); however, it is recognized that the diverse properties these materials may impart a 
range of toxicities. As an example, in a recent comparison of inflammatory responses to 
different types of CNTs administered to the peritoneum of mice, long thick MWCNTs 
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caused DNA damage and severe inflammatory effects, whereas similar SWCNTs caused 
little effect and short thin MWCNTs had no effect (Yamashita et al., 2010). These findings 
suggest important differences in the biological responses of CNFs/CNTs.
CNFs/CNTs have been produced for some years now, yet relatively few studies at facilities 
that produce/use these materials commercially have been reported (Maynard et al., 2004; 
Methner et al. 2007; Evans et al., 2010; Lee et al., 2010), and personal exposures were not 
monitored. Given the potential health hazards, there is an immediate need for toxicity and 
exposure data on CNFs/CNTs, with inhalation being the primary concern. An extensive 
study was conducted at a facility that manufactures and processes CNFs. Filter, sorbent, 
bulk sample, and microscopy analyses, combined with direct-reading instruments, provided 
complementary information regarding the composition, source, and concentrations of air 
contaminants. Samples were analyzed for organic and elemental carbon (OC and EC), 
metals, and polycyclic aromatic hydrocarbons (PAHs), with EC as a measure of CNFs. 
Transmission electron microscopy with energy-dispersive X-ray spectroscopy also was 
applied. Direct-reading results were reported previously (Evans et al., 2010). Findings for 
time-integrated samples are reported as companion papers in this issue. In addition to CNFs, 
fine/ultrafine iron-soot aerosol, PAHs, and carbon monoxide were found as production 
byproducts. OC and EC, metals, and microscopy results are reported in Part I (Birch et al., 
2011), whereas PAH results are reported herein.
FIELD SURVEYS
Facility and process description
The facility surveyed manufactures and processes vapor-grown CNFs. At the time of the 
surveys, annual production was ~31 000 pounds, and two different reactors, hereafter 
referred to as ‘A’ and ‘B’, were operating. The raw CNF products were collected in open 
boxes and taken to the processing area, where they were processed in multiple steps. As a 
final step, the CNF material was poured into a hopper feeding a thermal treatment system 
for removal of organic and metal impurities. The final product was discharged (openly) into 
a box containing a plastic bag. About 15 pounds were collected before the bag was manually 
removed, closed, and replaced. The facility had an open floor plan with ~ 22 000 square feet 
of floor space and ceilings ~18-feet high. Synthesis and processing operations were 
performed in different areas but these areas were not separated. A separate room with a large 
window to the plant was used as a control room. A small interlock area separated the plant 
from the control room and from the administrative areas, but it was not operating during the 
surveys. The administrative areas included several offices, a conference room, and a small 
kitchen. A complete facility description and details on operations are reported elsewhere 
(Birch et al., 2011; Evans et al., 2010).
Products
The CNF products are formed in the gas phase as an entangled mass. Based on the 
manufacturer’s specifications, the final product is a high-purity material that is 99.9% 
fibrous and has very low metal content. It is described as a highly graphitic, low-cost tubular 
material with walls composed of angled graphite sheets. The fibers have an outer chemically 
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vapor deposited (CVD) layer of carbon and an inner, tubular graphitic layer beneath the 
CVD layer. The fiber structure, called ‘stacked cup’ or ‘herringbone,’ has exposed edge 
planes along the surface. These highly reactive edge sites allow chemical modification for 
maximum reinforcement in polymer composites. Fiber diameters range from 70 to 200 nm, 
significantly larger than SWCNTs (e.g. 1–3 nm). The length of the as-produced fibers is 
estimated to be from 50 to 200 μm. Different grades are available and depend on the type of 
thermal treatment received.
Air monitoring
Air monitoring was conducted over a total of 4 days: two consecutive days in December and 
on 1 day during the first and second weeks of February. Four locations inside the facility 
were monitored: (i) the CNF reactor (synthesis) area, (ii) the thermal treatment area, (iii) a 
plant background area, and (iv) a conference room in an office area. Samples also were 
collected outdoors as a measure of environmental background.
METHODS
Air samples were collected at 2 l min−1 (AirChek 2000 pumps, SKC Cat. No. 210-2002) 
with OVS-7 sorbent tubes (XAD-7 resin/glass fiber filter; SKC 226-57). Sampling periods 
were ~6h, and two (paired) tubes were used at each sampling location. For the PAH 
analyses, each section of the tube (front filter and front and back sorbent sections) was 
removed and placed into separate 40-ml vials. Ten microliter of a 100 p.p.m. surrogate 
standard solution containing nitrobenzene-d5, 2-fluorobiphenyl, and 4-terphenyl-d12 was 
spiked into each sample section. The individual sections were then desorbed in an ultrasonic 
bath for 30 min with 2 ml of methylene chloride. After sonication, 1 ml of desorption 
solvent was transferred to a 2-ml vial and 5 μl of a 1000 μg μl−1 internal standard solution 
containing naphthalene-d8, acenaphthene-d10, phenanthrene-d10, chrysene-d12, and 
perylene-d12 was added. The sample was briefly mixed on a vortex mixer and analyzed by 
gas chromatography–mass spectrometry with selected ion monitoring (GC–MS SIM). 
Laboratory control samples included two media blanks and two sets of media spiked with 
standards.
The following equipment and conditions were used for PAH analyses: instrument: Hewlett 
Packard 5890 II GC and 5972 MS detector. GC conditions: Restek Rxi-5MS capillary 
column, 30 m, 0.25 mm inner diameter, and 0.25 μm film thickness; 1.5 ml min−1 column 
flow; injection temperature of 280°C; 2-μl injection volume; initial oven temperature at 
85°C with 0.5 min hold time; 12°C min−1–290°C and hold 0.5 min; 20°C min−1 to final 
temperature of 330°C with 1.0 min hold time. MS conditions: SIM scan mode with Group 1 
scan starting at 2.0 min, Group 2 at 8.2 min, and Group 3 at 15.3 min (see Table 1 for 
quantitation and secondary ions). The limits of detection and quantitation (LOD and LOQ) 
were determined through analysis of media spikes. Because sections of the sorbent tube 
were analyzed separately, an LOD–LOQ study was performed for each section. The LOD–
LOQ results (as micrograms per sample) were based on a 2-ml extraction volume.
In addition to air samples, three bulk samples of CNFs were analyzed: two raw 
(unprocessed) CNF products, one from each reactor, and a final processed (heat treated) 
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product. Samples were preweighed into amber glass vials and extracted three times with 10 
ml of methylene chloride. Sample weights were as follows: Reactor A unprocessed CNF: 
117.9 mg, Reactor B: 496.6 mg, and final product: 865.1 mg. The surrogate solution 
(nitrobenzene-d5, 2-fluorobiphenyl, and 4-terphenyl-d12) was added to the sample prior to 
extraction. With each extraction, the sample was shaken for 2 min. The three extracts were 
combined and concentrated to 1.0 ml except for one sample (Reactor A), which could only 
be concentrated to 5 ml. Analysis conditions were the same as those for the filter samples 
except the MS scan began at 1.5 min and was in full scan mode, from 35 to 500 amu. The 
LOD and LOQ and calibration ranges for the bulk samples are based on an initial weight of 
1 kg and final extraction volume of 1 ml. The actual LOD and LOQ depend on the weight of 
sample extracted. The LODs and LOQs for the laboratory control samples and blanks are 
based on an initial weight of 15 g, the amount of solid reagent used for blank extraction. The 
sample from Reactor B required dilution; the LODs and LOQs were adjusted accordingly. 
Laboratory control samples included one media blank (laboratory reagents only) prepared 
and analyzed with the sample set and one set of laboratory control spikes (standards spiked 
into the reagents).
RESULTS AND DISCUSSION
PAHs are pervasive environmental contaminants that result from incomplete combustion 
processes. In the workplace, they are commonly associated with industrial processes in 
which carbonaceous materials (e.g. coke, coal tar and pitch, asphalt oils) are produced or 
used (Bjerseth and Becher, 1986). The health hazards of PAHs are well established (Bjerseth 
and Becher, 1986; CRC Press, 1988; ATSDR 1996; Tsai et al., 2001; Kuo et al., 2003; 
Omar et al., 2006; Yang and Xing, 2006; Srogi, 2007). Many are carcinogens thought to 
exert their effects through formation of PAH–DNA adducts (Miller and Miller, 1981; Jerina 
et al., 1990; Kriek et al., 1998; Rogan, et al., 1993; Chakravarti, et al., 1995). Several PAHs 
have caused cancer in animal studies when inhaled, ingested, or applied to the skin 
(ATSDR, 1996). Their toxicity is highly structure dependent, ranging from nontoxic to 
extremely toxic for isomers of a given compound. The US Environmental Protection 
Agency (US EPA) has promulgated 16 PAHs as priority pollutants (Table 1). Eight of these 
are considered possible carcinogens: benz(a)anthracene, chrysene, benzo(b)fluoranthene, 
benzo(k)fluoranthene, benzo(a)pyrene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene, and 
benzo(g,h,i)-perylene (ATSDR, 1996). The following PAHs have been recognized for 
carcinogenic, mutagenic, and teratogenic properties: benz(a)anthracene, chrysene, 
benzo(b)fluoranthene, benzo(j)fluoranthene, benzo(k)-fluoranthene, benzo(a)pyrene, 
benzo(g,h,i)perylene, coronene, dibenz(a,h)anthracene, indeno(1,2,3-cd)pyrene, and ovalene 
(Luch, 2005). Benzo(a)pyrene in particular has been identified as being highly carcinogenic.
Average PAH concentrations in different areas of the facility during the first two survey 
days are reported in Fig. 1 (n = 4; error bars represent 1 SD). Naphthalene and 
acenaphthylene (Fig. 1a) were the dominant PAHs with average concentrations ranging 
from 115 to 298 μg m−3 and 35 to 63 μg m−3, respectively. Concentrations of other PAHs 
(Fig. 1b), including phenanthrene, fluorene, fluoranthene, anthracene, acenapthene, and 
pyrene, ranged from ~1 to 6 μg m−3. Results for two media blanks and two samples 
collected outdoors were non detect.
BIRCH Page 5













Similar findings (Fig. 2a,b) were obtained for samples collected on 2 days, 2 months later 
(in February). Naphthalene concentrations near Reactor A were 453 μg m−3 and 219 μg m−3, 
giving an average concentration of 336 μg m−3 (Fig. 2a) for the 2 days, which is consistent 
with that found previously (298 μg m−3). Corresponding concentrations in the thermal 
treatment area were 109 μg m−3 and 142 μg m−3, similar to the previous average (115 μg 
m−3). The concentrations of acenaphthalene in these areas were 84 μg m−3 in the Reactor A 
area and 44 μg m−3 in the thermal treatment area on the first day, and, respectively, 83 μg 
m−3 and 61 μg m−3 on the second, again comparable to results found previously. 
Concentrations of other PAHs (Fig. 2b) also were similar to previous results, ranging from 
~0.5 μg m−3 to 10 μg m−3. Average air concentrations of naphthalene and acenaphthylene 
and other PAHs in different areas of the facility over all four survey days are reported in Fig. 
3a,b (n = 8; error bars represent 1 SD).
Except for naphthalene, all results for the front filter sections of the OVS samplers were 
below the LOD (0.1–0.4 μg per sample) or LOQ (0.34 to 1.0 μg per sample) on all survey 
days. During the December surveys (Fig. 1), in the thermal treatment area, naphthalene on 
the front filter would have contributed only a minor amount (1.81 μg m−3) to the air 
concentration (115 μg m−3) determined with the front sorbent result, which is expected 
given its volatility. The amount of acenaphthylene and benzo(g,h,i)perylene on the front 
filter corresponded to air concentrations of 0.46 μg m−3 and 0.62 μg m−3, respectively, both 
between the LOD and LOQ for these compounds. The acenaphthylene concentration 
determined with the result for the front sorbent was ~34 μg m−3, whereas benzo(g,h,i) 
perylene was found only on the front filter (and in bulk samples as discussed below), 
indicating its particulate form rather than vaporous. Similar results for front filters were 
found in the Reactor A area: 6.20 μg m−3 for naphthalene (298 μg m−3 with front sorbent), 
0.89 μg m−3 for acenaphthylene (63 μg m−3 with front sorbent), and 2.23 μg m−3 for 
benzo(g,h,i)perylene (on front filter only). The same trend was found for the plant 
background samples. The front filter contributed 2.96 μg m−3 naphthalene, relative to 136 μg 
m−3 for the front sorbent; 0.65 μg m−3 acenaphthylene, relative to 35 μg m−3 for the front 
sorbent; and 0.96 μg m−3 benzo(g,h,i)perylene, with nondetect for the front sorbent.
Except for naphthalene, the amounts of PAHs on the back sorbent sections of the OVS 
samplers were negligible and therefore not reported. During the first two survey days (in 
December), the amount on the back section (i.e. breakthrough) was typically <2% of that 
found on the front section. Results were similar for the samples collected in February, but 
for several samples (with highest loadings), the amounts on the back section were higher, 
between ~6 and 10% of that on the front section.
Results for the three bulk materials, two raw CNF products from Reactors A and B and a 
final, processed product, are reported in Fig. 4 and Table 2. All results for bulk samples 
were either nondetect or above the LOQ, which depended on the amount of sample extracted 
and the individual PAH. Limits for target analytes in the three materials were LOD = 3.0–
4.0 mg kg−1 and LOQ = 11.0–13.0 mg kg−1 for Reactor A, LOD = 0.2–2.0 mg kg−1 and 
LOQ = 0.5–5.7 mg kg−1 for Reactor B, and LOD = 0.1 mg kg−1 and LOQ = 0.3–0.4 mg 
kg−1 for the final product. Several non-target analytes also are reported based on a library 
(MS) search. Results for non-target analytes are considered estimates.
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The top three PAHs in both of the raw products were pyrene, benzo(g,h,i)perylene, and 
fluoranthene, with concentrations of 2200, 1600, and 910 mg kg−1 for the Reactor A 
material and 1300, 750, and 570 mg kg−1 for the Reactor B material. In general, the PAHs 
common to both the products were higher in the Reactor A product. In ascending order, with 
concentrations ranging from 780 to 25 mg kg−1; other PAHs in product A included 
dibenzo(def,mno)chrysene, phenanthrene, benzo(a)pyrene, indeno(1,2,3-cd)pyrene and 
acenaphthylene, benzo(e)pyrene, cyclopenta(cd)pyrene, benzo(b)fluoranthene, anthracene, 
naphthalene, chrysene, benz(a)anthracene, and dibenz(a,h)anthracene. Product B also 
contained these PAHs, but the relative distribution differed. In addition, product B contained 
the following PAHs not found in product A: fluorene, coronene, benzo(k)fluoranthene, 
benzene,1,1′-(1,3-butadiyene-1,4-diyl)bis, acenaphthene, and 4H-
cyclopenta(def)phenanthrene. Excluding the top three PAHs (i.e. pyrene, 
benzo(g,h,i)perylene, and fluoranthene), the PAH concentrations for product B ranged from 
510 to 4.2 mg kg−1. As expected, due to thermal treatment, PAH levels in the final product 
were much lower, with the exception of coronene at 430 mg kg−1. Coronene was not found 
in the Reactor A product and was at 13 mg kg−1 in the Reactor B product. Other PAHs in 
the final product were benzo(g,h,i)perylene (5.1 mg kg−1), naphthalene (1.7 mg kg−1), 
pyrene (0.68 mg kg−1), and acenaphthylene (0.62 mg kg−1).
Occupational exposure to PAHs should be controlled to an extent that is practically feasible, 
but there are few set limits for assessing exposure to individual PAHs. Air concentrations 
(Figs. 1,2) of target PAHs having established exposure limits were well below those limits 
(Table 1). By comparison, the mean phenanthrene concentration reported for a study 
population of 284 workers ‘highly exposed’ to PAHs during the manufacture of refractory 
products (graphite electrode production, coke oven operation, tar distillation, and steel 
production) was 4.81 μg m−3 (Pesch et al., 2007), while it ranged from ~5 to 9 μg m−3 in 
this study. In another cross-industry study (Unwin et al., 2006), 8-h time-weighted average 
(TWA) concentrations of BaP ranged from <0.01 to 6.21 μg m−3, with a geometric mean of 
0.036 μg m−3. In this study, BaP was found in the bulk materials, but it was not detected in 
the air samples. Differences in the relative abundances and types of PAHs present depend on 
their sources and processes by which they are formed. All the PAHs found in this study are 
EPA priority pollutants, and seven (Reactor A sample) and eight (Reactor B sample) of the 
PAHs found in two unpurified products are considered possible carcinogens (ATSDR, 
1996).
Concentrations of naphthalene were highest but still well below current occupational 
exposure levels. The Occupational Safety and Health Administration (OSHA) permissible 
exposure limit (OSHA, 2001), NIOSH REL (NIOSH, 2005), and American Conference of 
Governmental Industrial Hygienists (ACGIH) threshold limit value (TLV) (ACGIH, 2009) 
are all 50 mg/m3 as an 8-h TWA, but there is uncertainty about whether the standard is 
protective enough. Concerns about naphthalene exposure and efforts to reassess the 
inhalation risks have been in a state of flux (NTP, 2004; Jia and Batterman, 2010) since its 
potential carcinogenicity was reported (NTP, 2000). The US EPA had set a chronic 
reference concentration (RfC) of 3 μg m−3 (US EPA, website), while the Agency for Toxic 
Substances and Disease Registry (ATSDR) set an inhalation minimal risk level (chronic) at 
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3.6 μg m−3 (ATSDR, 2009), and the Office of Environmental Health Hazard Assessment 
(OEHHA, California) set an inhalation REL (chronic) at 9 μg m−3 (OEHHA, 2000). A 
revision to a 1998 EPA risk assessment (US EPA, 1998) was made that updates the 
inhalation cancer risk, along with noncancer and oral risks (US EPA, 2004). The update was 
based mainly on a National Toxicology Program (NTP) animal inhalation study that found 
increased risk of rare nasal tumors (NTP, 2000). Naphthalene’s carcinogenic potential was 
increased by a factor of three and it was listed as a probable human carcinogen (US EPA, 
2004); however, both the EPA (US EPA, 2004; Magee et al., 2010) and IARC (IARC, 2002) 
considered the epidemiological evidence for determining the human carcinogenicity of 
naphthalene inadequate. Still, new information and risk assessment methods used in the 
revision lower the exposure limit substantially, to 0.01 μg m−3 for chronic inhalation and 
cancer risk of 10−6; the final assessment is expected in 2012 (Jia and Batterman, 2010). 
Limit values for other countries have been summarized by IARC (IARC, 2002), and a report 
on development of indoor air guidelines for naphthalene was issued by the World Health 
Organization (WHO, 2006).
CONCLUSIONS
Filter, sorbent, impactor, microscopy, and bulk samples, combined with direct-reading 
monitoring, provided complementary information on air contaminants generated during 
manufacture and processing of CNFs. Worker exposure was to a complex mixture of CNFs, 
fine/ultrafine iron-rich soot (Birch et al., 2011), CO (Evans et al., 2010), and PAHs. The 
presence of PAHs in unpurified CNFs is a health concern and suggestive of their presence in 
unpurified CNF/CNT products generally. PAHs are formed under conditions employed for 
synthesis of vapor-grown CNFs (and CNTs), and these materials can have high sorptive 
capacity for PAHs and other organic compounds (Yang and Xing, 2006).
Raw and purified products, byproducts, and other workplace emissions should be considered 
when assessing the exposure risks of CNFs/CNTs and other nanoscale carbons. The 
potential health effects may be additive or synergistic with co-exposures. Systematic studies 
of complex mixtures are needed to better understand how interactions between components 
may influence aerosol toxicity. Inhalation of CNFs/CNTs is the primary health concern and 
was the focus of this study, but dermal contact and ingestion are potential exposure routes 
that merit future investigation. Given the potential inhalation risks suggested by animal 
studies, efforts to reduce and control exposure to CNFs/CNTs are prudent.
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a) Average concentrations of naphthanene and acenaphthylene in different areas over two 
survey days in December. (b) Average PAH concentrations in different areas over two 
survey days in December.
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a) Average concentrations of naphthalene and acenaphthylene in different areas over two 
survey days in February. (b) Average PAH concentrations in different areas over two survey 
days in February.
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a) Average concentrations of naphthalene and acenaphthylene in different areas over all 
survey days (four total). (b) Average PAH concentrations in different areas over all survey 
days (four total).
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PAH results for three bulk CNF samples of unprocessed products from Reactors A and B 
and a final product.
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